RPE Cell Bystander Effects Contribute to AMD Pathology
RPE Cell Bystander Effects Contribute to AMD Pathology
批准号:
10514599
负责人:
Baerbel Rohrer
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2024-09-30
关键词:
AffectAgeAge related macular degenerationAmericanBiologyBlindnessBruch&aposs basal membrane structureBystander EffectCalciumCaringCellsCellular StressCessation of lifeChoroidChronicCommunicationComplementComplement 3aComplement ActivationComplement InactivatorsComplexComplicationDevelopmentDiseaseDrusenElastasesEpigenetic ProcessExperimental DesignsFamily suidaeFundingFutureGap JunctionsGeneticGoalsHDAC6 geneHaplotypesHomeostasisHybridsIncidenceIndividualInflammationKnowledgeLifeLocationMediatingMediatorMelaninsMembrane PotentialsMetabolicMetabolismMitochondriaMitochondrial DNAMolecular AbnormalityOrganellesOxidative StressPathologicPathologyPhotoreceptorsPopulationPrevalenceProductionReceptor SignalingResearchRiskRoleSeveritiesSignal TransductionSmokingStressStructure of retinal pigment epitheliumSystemTestingTherapeuticVeteranscell injurycomplement C3a receptorcomplement systemdesignexamination questionsexosomegeographic atrophyinduced pluripotent stem cellmitochondrial dysfunctionmitochondrial membranemitochondrial metabolismmonolayerreceptorresponserisk varianttransmission processuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Age-related macular degeneration (AMD) is a slowly progressing multifactorial disease involving genetic ab-
normalities and environmental insults. AMD is the leading cause of blindness for Americans over age sixty.
Since smoking, a major cause of oxidative stress, significantly increases the risk of AMD and there is a 20%
higher incidence of smoking in veterans than in the general U.S. civilian population, the VA system will have to
provide care for potentially >7 million AMD cases. The current concepts of AMD recognize that chronic oxida-
tive stress and inflammation (including complement activation) can trigger pathological changes in RPE,
Bruch’s membrane (BrM) and choroid. Major efforts to develop new AMD therapeutics have been focused on
complement inhibitors. However, to date, all targets within the complement cascade have failed. We pose
that one complication not yet considered is the potential issue of intracellular complement signaling. The
overarching goal is to determine how damage signals leading to mitochondrial dysfunction are spread
throughout the RPE monolayer, and to elucidate the contribution of intracellular complement signaling. Using
highly differentiated RPE cells we have made significant progress demonstrating that oxidative stress
changes the cargo in exosomes that are released from cells and that those exosomes induce short- and
long-term changes in recipient RPE. Importantly, we found that long-term changes triggered by exosomes
included changes in mitochondrial homeostasis and have identified potential mediators. Likewise, we
showed that oxidative stress triggers mitochondrial membrane potential and calcium changes in an individual
stressed cell that is then propagated through gap junctions to receptive cells. A receptive cell was identified
as a cell with high baseline calcium, less negative membrane potential and low melanin levels. Based on the
new knowledge identified in the previous funding period, we wish to expand on the following hypotheses. 1)
As it is now accepted that an overactive complement system is tied to AMD incidence, we propose to investi-
gate the contribution of intracellular complement signaling in mitochondrial damage and ensuing pathology.
And 2) as mitochondria are the organelles responsible for energy production and making life/death decisions
in a cell, we wish to determine the contribution of exosomes to the transfer of information to recipient cells.
Two aims were designed to answers those questions. Aim 1 tests the prediction that intracellular calcium
and complement signaling contribute to mitochondrial stress in the RPE network; Aim 2 tests the prediction
that exosomal content alters intracellular milieu resulting in changes in mitochondrial homeostasis in the
RPE network. We will test questions in three sets of cells with different features: ARPE-19, which can easily
be manipulated; second, we will use J and H mitochondrial cybrids, in which the J haplotype is associated
with increased risk for AMD; and third, we will examine questions in iPSC-RPE cells with Chr1 versus Chr10
risk alleles and their isogenic controls. These studies will have important implication in AMD biology. First,
knowledge about the role of intracellular complement signaling in mitochondrial metabolism, and second, elu-
cidating how endogenous signaling transmitted via exosomes can alter mitochondrial homeostasis within the
RPE, together will have important consequences for the future development of AMD therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration
-
批准号:10563120
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2020
-
负责人:Baerbel Rohrer
-
依托单位:
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration
-
批准号:10312122
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2020
-
负责人:Baerbel Rohrer
-
依托单位:
Sex and Gender Supplement to Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration
-
批准号:10334019
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2020
-
负责人:Baerbel Rohrer
-
依托单位:
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration
-
批准号:9885803
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2020
-
负责人:Baerbel Rohrer
-
依托单位:
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration
-
批准号:10077557
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2020
-
负责人:Baerbel Rohrer
-
依托单位:
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer
-
批准号:10515291
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Baerbel Rohrer
-
依托单位:
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer
-
批准号:10293580
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Baerbel Rohrer
-
依托单位:
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer
-
批准号:10047234
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Baerbel Rohrer
-
依托单位:
RPE Cell Bystander Effects Contribute to AMD Pathology
-
批准号:10015692
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Baerbel Rohrer
-
依托单位:
RPE Cell Bystander Effects Contribute to AMD Pathology
-
批准号:10293593
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Baerbel Rohrer
-
依托单位:
RPE Cell Bystander Effects Contribute to AMD Pathology
-
批准号:9137278
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Baerbel Rohrer
-
依托单位:
ECT Implants for Factor H Delivery in Models of AMD
-
批准号:8919367
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2014
-
负责人:Baerbel Rohrer
-
依托单位:
ECT Implants for Factor H Delivery in Models of AMD
-
批准号:9132253
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2014
-
负责人:Baerbel Rohrer
-
依托单位:
ECT Implants for Factor H Delivery in Models of AMD
-
批准号:8750307
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2014
-
负责人:Baerbel Rohrer
-
依托单位:
Complement Factor H-based Therapeutic Strategies in Macular Degeneration
-
批准号:10261459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Baerbel Rohrer
-
依托单位:
Alternative Pathway of Complement Activation in Age-Related Macular Degeneration
-
批准号:8500295
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2010
-
负责人:Baerbel Rohrer
-
依托单位:
Complement Factor H Haplotypes and Smoking in Age-Related Macular Degeneration
-
批准号:8181318
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Baerbel Rohrer
-
依托单位:
Complement Factor H-based Therapeutic Strategies in Macular Degeneration
-
批准号:9394727
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Baerbel Rohrer
-
依托单位:
Complement Factor H Haplotypes and Smoking in Age-Related Macular Degeneration
-
批准号:8916644
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Baerbel Rohrer
-
依托单位:
Alternative Pathway of Complement Activation in Age-Related Macular Degeneration
-
批准号:8288204
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2010
-
负责人:Baerbel Rohrer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: